81. Congenital adrenal hyperplasia Clinical trials / Disease details

Clinical trials : 87 / Drugs : 87 - (DrugBank : 23) / Drug target genes : 12 - Drug target pathways : 68

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04536662 (ClinicalTrials.gov)	October 1, 2020	23/8/2020	Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21a-hydroxylase Deficiency	Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21a-hydroxylase Deficiency	Congenital Adrenal Hyperplasia	Drug: Hydrocortisone;Drug: Prednisone;Drug: Dexamethasone	Shanghai Jiao Tong University School of Medicine	NULL	Not yet recruiting	14 Years	45 Years	All	120	Phase 4	China
2	NCT03760835 (ClinicalTrials.gov)	August 11, 2016	9/11/2018	Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment	Congenital Adrenal Hyperplasia: Innovative Once Daily Dual Release Hydrocortisone Treatment	Congenital Adrenal Hyperplasia	Drug: Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone);Drug: Dual release hydrocortisone (plenadren)	Federico II University	NULL	Recruiting	18 Years	N/A	All	150	Phase 4	Italy